How should I reconstitute 36 mg of retatrutide to obtain a concentration of 4 mg per milliliter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reconstituting 36 mg of Retatrutide to 4 mg/mL

To achieve a concentration of 4 mg/mL from 36 mg of retatrutide, add 9 mL of sterile diluent (bacteriostatic water or sterile water for injection) to the vial.

Calculation Method

The basic reconstitution formula is straightforward:

  • Desired concentration = Total drug amount ÷ Total volume
  • Required volume = Total drug amount ÷ Desired concentration
  • 9 mL = 36 mg ÷ 4 mg/mL 1

This yields exactly 4 mg per milliliter in the final solution.

Reconstitution Procedure

Preparation Steps

  • Use aseptic technique throughout the entire reconstitution process to prevent contamination and maintain sterility 1
  • Gather all necessary supplies before beginning: the retatrutide vial, appropriate volume syringe (10 mL), sterile diluent, alcohol swabs, and proper labeling materials 1
  • Allow the retatrutide vial and diluent to reach room temperature (approximately 30 minutes if refrigerated) before reconstitution to ensure proper mixing 1

Mixing Technique

  • Draw up exactly 9 mL of sterile diluent using a sterile syringe, ensuring accurate measurement 1
  • Inject the diluent slowly down the side of the vial rather than directly onto the powder to minimize foaming 1
  • Gently swirl the vial in a circular motion until the powder is completely dissolved; do not shake vigorously as this can denature the peptide 1
  • Inspect the solution visually to ensure it is clear and free of particulates before use 1
  • Remove any air bubbles by holding the vial upright and gently tapping the side 1

Critical Labeling Requirements

Proper labeling is essential to prevent medication errors and ensure safe administration 1:

  • Patient identification (name and medical record number)
  • Medication name: "Retatrutide"
  • Concentration: "4 mg/mL"
  • Total volume: "9 mL"
  • Total drug amount: "36 mg"
  • Diluent used: specify type (e.g., "bacteriostatic water")
  • Date and time of reconstitution
  • Preparer's initials or identification
  • Expiration date/time (based on stability data or manufacturer recommendations)
  • Storage requirements (typically refrigerated 2-8°C) 1

Common Pitfalls to Avoid

  • Do not use expired diluent or retatrutide, as this compromises both safety and efficacy 1
  • Avoid vigorous shaking, which can cause protein aggregation and reduce drug potency 1
  • Do not use if the solution appears cloudy, discolored, or contains particles after reconstitution 1
  • Never mix retatrutide with other medications in the same vial 1
  • Ensure accurate volume measurement; even small errors in the diluent volume will alter the final concentration significantly 1

Storage and Stability

  • Store the reconstituted solution in the refrigerator at 2-8°C unless manufacturer guidelines specify otherwise 1
  • Protect from light during storage to maintain stability 1
  • Use within the timeframe specified by stability data (typically 28 days for peptide medications when using bacteriostatic water, but verify with product-specific information) 1
  • Discard any unused portion after the expiration date/time indicated on the label 1

Verification Before Administration

  • Double-check the concentration calculation before first use: 4 mg/mL means each 1 mL contains 4 mg of retatrutide 1
  • Confirm the dose prescribed matches what can be accurately drawn from this concentration 1
  • Verify the route of administration is subcutaneous, as retatrutide is administered subcutaneously once weekly 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.